[Therapeutic goal and pharmacotherapy according to clinical stages of schizophrenia].

Koichi Furuhashi, Nakao Iwata

Research output: Contribution to journalReview article

Abstract

Schizophrenia is chronically progressed disease with a functional decline and adequate treatment is needed for respective clinical stages. Duration of psychosis before treatment is called DUP (duration of untreated psychosis) and may be an important predictor of outcome. Furthermore, the early phase of schizophrenia including DUP is considered a critical period, in which long-term outcome is predictable. Therefore, that shows the importance of early detection and intervention for schizophrenia and relapse prevention during a critical period. The atypical antipsychotics now play the leading role in pharmacotherapy of schizophrenia. They clearly decrease adverse effects, and may prevent the relapse and improve long-term outcome. However, better pharmacotherapy needs the viewpoint of adherence and we do not have to remember the importance of psychosocial therapy.

Original languageEnglish
Pages (from-to)635-640
Number of pages6
JournalNihon rinsho. Japanese journal of clinical medicine
Volume71
Issue number4
Publication statusPublished - 01-01-2013

Fingerprint

Schizophrenia
Psychotic Disorders
Drug Therapy
Therapeutics
Secondary Prevention
Antipsychotic Agents
Recurrence
Critical Period (Psychology)

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{f544475eca3e408dac391fd993e6b118,
title = "[Therapeutic goal and pharmacotherapy according to clinical stages of schizophrenia].",
abstract = "Schizophrenia is chronically progressed disease with a functional decline and adequate treatment is needed for respective clinical stages. Duration of psychosis before treatment is called DUP (duration of untreated psychosis) and may be an important predictor of outcome. Furthermore, the early phase of schizophrenia including DUP is considered a critical period, in which long-term outcome is predictable. Therefore, that shows the importance of early detection and intervention for schizophrenia and relapse prevention during a critical period. The atypical antipsychotics now play the leading role in pharmacotherapy of schizophrenia. They clearly decrease adverse effects, and may prevent the relapse and improve long-term outcome. However, better pharmacotherapy needs the viewpoint of adherence and we do not have to remember the importance of psychosocial therapy.",
author = "Koichi Furuhashi and Nakao Iwata",
year = "2013",
month = "1",
day = "1",
language = "English",
volume = "71",
pages = "635--640",
journal = "Nippon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "4",

}

[Therapeutic goal and pharmacotherapy according to clinical stages of schizophrenia]. / Furuhashi, Koichi; Iwata, Nakao.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 71, No. 4, 01.01.2013, p. 635-640.

Research output: Contribution to journalReview article

TY - JOUR

T1 - [Therapeutic goal and pharmacotherapy according to clinical stages of schizophrenia].

AU - Furuhashi, Koichi

AU - Iwata, Nakao

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Schizophrenia is chronically progressed disease with a functional decline and adequate treatment is needed for respective clinical stages. Duration of psychosis before treatment is called DUP (duration of untreated psychosis) and may be an important predictor of outcome. Furthermore, the early phase of schizophrenia including DUP is considered a critical period, in which long-term outcome is predictable. Therefore, that shows the importance of early detection and intervention for schizophrenia and relapse prevention during a critical period. The atypical antipsychotics now play the leading role in pharmacotherapy of schizophrenia. They clearly decrease adverse effects, and may prevent the relapse and improve long-term outcome. However, better pharmacotherapy needs the viewpoint of adherence and we do not have to remember the importance of psychosocial therapy.

AB - Schizophrenia is chronically progressed disease with a functional decline and adequate treatment is needed for respective clinical stages. Duration of psychosis before treatment is called DUP (duration of untreated psychosis) and may be an important predictor of outcome. Furthermore, the early phase of schizophrenia including DUP is considered a critical period, in which long-term outcome is predictable. Therefore, that shows the importance of early detection and intervention for schizophrenia and relapse prevention during a critical period. The atypical antipsychotics now play the leading role in pharmacotherapy of schizophrenia. They clearly decrease adverse effects, and may prevent the relapse and improve long-term outcome. However, better pharmacotherapy needs the viewpoint of adherence and we do not have to remember the importance of psychosocial therapy.

UR - http://www.scopus.com/inward/record.url?scp=84891696418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891696418&partnerID=8YFLogxK

M3 - Review article

C2 - 23678592

AN - SCOPUS:84891696418

VL - 71

SP - 635

EP - 640

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 4

ER -